MS & Neuromuscular Center of Excellence

Clearwater, Florida 33761

0 studies enrolling now · 1 studies all time

What they study most

Advancing Multiple Sclerosis, Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients — Completed